Cells in our body communicate with their surroundings through tiny nanomachines called G protein-coupled receptors (GPCRs) that are embedded in the outermost membrane which wraps the cell. Owing to their crucial role in maintaining key cellular processes, these receptors have emerged as major drug targets in almost all clinical areas. The serotonin1A receptor is one… Continue reading Cholesterol and fate of drug targets of depression

On April 12, 2020 CSIR-Centre for Cellular and Molecular Biology, Hyderabad was identified by Indian Council of Medical Research (ICMR) to be one of the five validation centres for COVID-19 testing in India. CSIR-CCMB is the only non-ICMR lab to be a part of these Centres of Excellence that will validate the non-US FDA and… Continue reading CCMB to validate COVID-19 testing kits along with ICMR labs

Under this agreement, CCMB will use Eyestem’s human lung epithelial cell culture system provided as part of its Anti-Covid screening (ACS) platform to understand the molecular and pathological characteristics of the COVID-19 virus with a view to establishing a rational basis for testing potential drugs in vitro. Commenting on the development, Dr. Rakesh Mishra, Director of… Continue reading CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad & Eyestem Research Private Limited, Bangalore announce a unique public-private collaboration in the fight against Covid-19

Hyderabad, 3rd May, 2021: The dry swab based direct RT-PCR method of COVID-19 testing, developed by CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad and approved by ICMR can now be adopted in testing labs of the country. This method is easier to carry out than the current procedures, and can ramp up testing by… Continue reading CCMB offers training of ICMR-approved testing centres to adopt a faster COVID-19 testing method